Advertisement

The mystery of nitrate resistance

  • Jonathan Abrams
    Correspondence
    Address for reprints: Jonathan Abrams, MD, the Department of Medicine/Cardiology Division, the University of New Mexico School of Medicine, University of New Mexico Hospital, 7 South, 2211 Lomas Boulevard NE, Albuquerque, New Mexico 87131.
    Affiliations
    From the Department of Medicine/Cardiology Division, the University of New Mexico School of Medicine, University of New Mexico Hospital, Albuquerque, New Mexico USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Armstrong PW
        • Armstrong JA
        • Marks GS
        Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
        Circulation. 1980; 62: 160-166
        • Magrini F
        • Niarchos AP
        Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema.
        Am J Cardiol. 1980; 45: 841-847
        • Elkayam U
        • Henriquez B
        • Weber L
        • Tonnemacher D
        • Rahimtoola SH
        Lack of hemodynamic effect of high dose transdermal nitroglycerin in severe heart failure (abstr).
        Circulation. 1984; 70: II-114
        • Elkayam U
        • Roth A
        • Henriquez B
        • Weber L
        • Tonnemacher D
        • Rahimtoola SH
        The hemodynamic and hormonal effects of high dose transdermal nitroglycerin in patients with chronic congestive heart failure.
        Am J Cardiol. 1985; 56: 555-559
        • Roth A
        • Kulick D
        • Freidenberger L
        • Hong R
        • Rahimtoola SH
        • Elkayam U
        Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.
        J Am Coll Cardiol. 1987; 9: 858-864
        • Elkayam U
        • Kulick D
        • McIntosh N
        • Roth A
        • Hsueh W
        • Rahimtoola SH
        Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.
        Circulation. 1987; 76: 577-584
        • Armstrong PW
        Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
        J Am Coll Cardiol. 1987; 9: 420-425
        • Kulick D
        • Roth A
        • McIntosh N
        • Rahimtoola SH
        • Elkayam U
        Resistance to isosorbide dinitrate in patients with severe chronic heart failure: incidence and attempts at hemodynamic prediction.
        J Am Coll Cardiol. 1988; 12: 1023-1028
        • Packer M
        • Medina N
        • Yushak M
        • Lee WH
        Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
        Am J Cardiol. 1986; 57: 260-267
        • Cohn JN
        • Archibald DG
        • Ziesche S
        • et al.
        Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administrative Cooperative Study.
        N Engl J Med. 1986; 374: 1547-1552
        • Cohn JN
        • Johnson G
        • Ziesche S
        • et al.
        A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
        N Engl J Med. 1991; 325: 303-310
        • Margolies KB
        • Hildebrand FL
        • Lerman A
        • Perella MA
        • Burrett Jr, JC
        Increased endothelin in experimental heart failure.
        Circulation. 1990; 82: 2226-2230
        • Luscher TF
        Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease.
        Eur Heart J. 1989; 10: 847-856
        • Rafflenbeul W
        • Bassenge E
        • Lichtlen P
        Competition between endothelium-dependent and nitroglycerin-induced coronary vasodilation.
        Z Kardiol. 1989; 78: 45-47
        • Dupuis J
        • Lalonde G
        • Lemieux R
        • Rouleau JL
        Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased volume, neurohumoral activation and lack of prevention with N-acetylcysteine.
        J Am Coll Cardiol. 1990; 16: 932-934
        • Packer M
        • Lee WH
        • Kessler PD
        • Gottlieb SS
        • Medina N
        • Yushak M
        Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
        N Engl J Med. 1987; 317: 799-804
        • Jordan RA
        • Seth L
        • Casebolt P
        • et al.
        Rapidly developing tolerance to transdermal nitroglycerine in congestive heart failure.
        Ann Intern Med. 1986; 104: 295-298
        • Parker JO
        Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
        J Am Coll Cardiol. 1989; 13: 794-795
        • Silber S
        • Vogler AC
        • Krause KH
        • Vogel M
        • Thiesen K
        Induction and circumvention of nitrate tolerance applying different dosage intervals.
        Am J Med. 1987; 83: 860-870
      1. Parker JD, Farrell B, Fenton J, Cohanim J, Parker JO. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation in press.

        • Loos D
        • Schneider R
        • Schorner W
        Changes in regional body blood volume caused by nitroglycerin.
        Z Kardiol. 1983; 72: 29-34
        • Manyari DE
        • Smith ER
        • Spragg J
        Isosorbide dinitrate and glyceryl trinitrate: demonstration of cross tolerance in the capacitance vessels.
        Am J Cardiol. 1985; 55: 927-933
        • Abrams J
        Hemodynamic effects of nitroglycerin and long-acting nitrates.
        Am Heart J. 1985; 110: 216-224
        • Packer M
        • Meller J
        • Medina N
        • Gorlin R
        • Herman MV
        Dose requirements of hydralazine in patients with severe chronic congestive heart failure.
        Am J Cardiol. 1980; 45: 655-660
        • Packer M
        • Lee WH
        • Medina M
        • Yushak M
        • Kessler P
        Identification of patients with severe heart failure most likely to fail long-term therapy with converting-enzyme inhibitors (abstr).
        J Am Coll Cardiol. 1986; 7: 18A
        • Leier C
        • Majorien RD
        • Desch CE
        • Thompson MJ
        • Unverferth DV
        Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.
        Circulation. 1981; 63: 102-109
        • Bauer JA
        • Fung H-L
        Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
        Circulation. 1991; 84: 35-39